United States · FDA National Drug Code directory
temazepam
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 55289-660_58b31552-c16f-5f7f-e063-6294a90ab7f8
- Product NDC
- 55289-660
- Form
- CAPSULE
- Composition / generic term
- temazepam
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 19870421
- Source listing expiry
- 20271231
Source-listed ingredients
- TEMAZEPAM — 30 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE, PLASTIC (55289-660-01) · 55289-660-01
- 30 CAPSULE in 1 BOTTLE, PLASTIC (55289-660-30) · 55289-660-30
- 60 CAPSULE in 1 BOTTLE, PLASTIC (55289-660-60) · 55289-660-60
- 500 CAPSULE in 1 BOTTLE, PLASTIC (55289-660-82) · 55289-660-82
- 90 CAPSULE in 1 BOTTLE, PLASTIC (55289-660-90) · 55289-660-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →